// App-Quantinova.ai

2694378 : The Natural History of the Progression of Choroideremia (NIGHT) Study: Longitudinal Changes in Visual Acuity over 12 Months

Researchers

Presenter

  • Mark E Pennesi

Principal Investigators

  • Byron L Lam

  • M Dominik Fischer

  • Eeva-Marja Kaarina Sankila

  • Frank G. Holz

  • Robert E MacLaren

  • David G Birch

  • Ian M MacDonald

  • Graeme Black

  • Carel C B Hoyng

  • Neil M Bressler

  • Stephen H. Tsang

  • Kimberly E Stepien

  • Michael S Ip

  • Vedran Pavlovic

  • Aniz Girach

Medical Centers

  • Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada

  • Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands

  • Ophthalmology, Casey Eye Institute - OHSU, Portland, Oregon, United States

  • Department of Ophthalmology and of Pathology and Cell Biology, Columbia University, New York, New York, United States

  • Retinafoundation of the Southwest, Dallas, Texas, United States

  • Nuffeild Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom

  • Doheny Eye Institute, Doheny Image Reading Center, University of California , Los Angeles, California, United States

  • Wilmer Eye Institute, The Johns Hopkins University, Baltimore, Maryland, United States

  • Nightstar Therapeutics plc, London, United Kingdom

  • Dept. of Ophthalmology, University Clinics, Bonn, Germany

  • Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States

  • Department of Urology, Helsinki University Hospital, Helsinki, Finland, Helsinki, Finland.

  • Bascom Palmer Eye Institute, University of Miami Health System, Pinecrest, Florida, United States

  • Central Manchester University Hospitals NHS Foundation Trust, Centre for GenomicMedicine, Manchester, United Kingdom

  • Center of Ophthalmology, University Tuebingen, Tuebingen, Germany

Locations

  • Canada

  • Netherlands

  • United States

  • United Kingdom

  • Germany

  • Finland

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A